Analyst Ratings for Harvard Bioscience Inc. (HBIO)
HBIO Rating Summary
HBIO Price Target Summary
- Highest: $7.50 (StoneX)
- Lowest: $7.50 (StoneX)
- Average: $7.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$7.50 (-8%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 63%
Rating Score: 6 / 10
Percentile Rank: 63%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/9/2025 | KeyBanc | Paul Knight | Downgrade | Sector Weight (Overweight) |
N/A (N/A) |
0.38 (8.15) |
2044.74% | Details |
| 3/10/2023 | StoneX » Updated 8/12/2026 |
Bruce Jackson | Upgrade | Buy (Speculative Buy) |
7.50 (6.00) |
2.66 (8.15) |
206.39% | Details |
 |
||||||||
|
||||||||
|
||||||||
